Genetically engineered, pharmaceutical rice is not a safe or cost-effective solution for infants suffering from diarrhea, concludes an exhaustive report released today by the Center for Food Safety, as the U.S. Dept. of Agriculture (USDA) considers whether to allow planting of the rice in Kansas this spring. The report discusses potential adverse health impacts of the rice-grown drugs, which have not been approved by the U.S. Food and Drug Administration (FDA).